Somatic hotspot mutations in isocitrate dehydrogenase 1 (IDH1) have been identified in a variety of cancers, with a frequency of ~7% in acute myeloid leukemia (AML) [1–6]. This evidence concerns the gene IDH1 and acute myeloid leukemia.